This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Linda M. Nagy, MD; John H. Krystal, MD; Dennis S. Charney, MD
Department of Psychiatry Yale University School of Medicine and Veterans Affairs Medical Center 116/A 950 Campbell Ave West Haven, CT 06516

Scott W. Woods, MD
New Haven, Conn

Arch Gen Psychiatry. 1991;48(9):861-862.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

We appreciate the letter supporting our finding that the antipanic and antiphobic efficacy of combined alprazolam and behavioral therapy is sustained following shortterm treatment. We reemphasize that we could not address the comparative efficacy of one or both forms of treatment, as all our patients received both medication and behavioral treatment. However, our data do address the issue of what happens when drug therapy is withdrawn, in that several patients maintained treatment gains when not receiving medication, and the vast majority maintained treatment gains while receiving substantially reduced doses of alprazolam.

Judd et al share interesting data regarding 12-month follow-up of patients with panic attacks treated with pharmacotherapy, some of whom also received behavioral therapy. It is unclear why 12 patients received adjunctive behavioral treatment. If treatments were not randomly assigned, it is likely that selection based on clinical features accounts for any differences between these groups. We also caution . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?